Venture Fellows will conceptualize, build, and launch biotech companies at the cusp of longevity science. You will work in a team of 2–3 peers, collaboratively panning the relevant literature to propose and support your thesis. Over the three month period, you will go from hundreds of ideas to 1-2 leads, culminating in a demo day at the end of the program. The best leads will receive funding from AGE1, our biotech accelerator program, and you will have the opportunity to continue with the company after the fellowship period or return to your academic program.
You will be responsible for identifying promising and potentially transformational science and devising a strategy to quickly and cheaply determine its translational viability. You will develop a broad understanding of the landscape, with deep dives into the biology around a few select targets and strategies. You will consider opportunities and risks from the basic biology to the competitive landscape and clinical trial design. Along the way, we will host experts on topics ranging from small molecule screen design to raising venture capital, along with regular journal clubs and lab meetings.
You are excited to ensure that science breakthroughs actually touch real patients.
You are excited to work with interdisciplinary scientists and engineers from machine learning, biology, chemistry and physics and ready to bridge the communication barriers between disciplines.
By the end of the three months, you will have: